Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
96
Frequently Asked Questions
What is Market Cap of Olema Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Olema Pharmaceuticals Inc market cap is $764.59M.
What is the 52-week high for Olema Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Olema Pharmaceuticals Inc 52 week high is $13.51 as of October 03, 2025.
What is the 52-week low for Olema Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Olema Pharmaceuticals Inc 52 week low is $2.86 as of October 03, 2025.
What is Olema Pharmaceuticals Inc stock price today?
Olema Pharmaceuticals Inc stock price today is $11.10.
What was Olema Pharmaceuticals Inc stock price yesterday?
Olema Pharmaceuticals Inc stock price yesterday was $11.14.
What is the PE ratio of Olema Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Olema Pharmaceuticals Inc’s P/E ratio is -5.79.
What is the Price-to-Book ratio of Olema Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Olema Pharmaceuticals Inc P/B ratio is 1.9852.
What is the 50-day moving average of Olema Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Olema Pharmaceuticals Inc 50-day moving average is $6.65.
How many employess does Olema Pharmaceuticals Inc has?
